LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - ANI Pharmaceuticals (NASDAQ: ANIP)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ANIP ANI Pharmaceuticals
Marken James G. / officer: SVP OPS & PROD DEV
04/10/2024
Sell
$66.96
2,799
$187K
116,006
NASDAQ ANIP ANI Pharmaceuticals
CAREY STEPHEN P. / officer: SVP & CFO
04/10/2024
Sell
$66.96
4,534
$304K
166,968
NASDAQ ANIP ANI Pharmaceuticals
Gassert Chad / officer: SVP - CORP. DEV. & STRATEGY
04/01/2024
Sell
$67.25
20,000
$1.345M
253,226
NASDAQ ANIP ANI Pharmaceuticals
CAREY STEPHEN P. / officer: SVP & CFO
03/23/2024
Sell
$69.58
6,210
$432K
171,502
NASDAQ ANIP ANI Pharmaceuticals
Marken James G. / officer: SVP OPS & PROD DEV
03/23/2024
Sell
$69.58
3,653
$254K
118,805
NASDAQ ANIP ANI Pharmaceuticals
Lalwani Nikhil / director, officer: PRESIDENT & CEO
03/23/2024
Sell
$69.58
17,455
$1.215M
394,174
NASDAQ ANIP ANI Pharmaceuticals
Cook Meredith / officer: SR. VP, GENERAL COUNSEL & SEC.
03/13/2024
Sell
$66.54
250
$17K
59,981
NASDAQ ANIP ANI Pharmaceuticals
Gassert Chad / officer: SVP - CORP. DEV. & STRATEGY
03/11/2024
Sell
$65.81
20,000
$1.316M
273,226
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
03/08/2024
Sell
$67.17
10,000
$672K
832,620
NASDAQ ANIP ANI Pharmaceuticals
CAREY STEPHEN P. / officer: SVP & CFO
03/07/2024
Sell
$66.71
4,216
$281K
185,499
NASDAQ ANIP ANI Pharmaceuticals
CAREY STEPHEN P. / officer: SVP & CFO
03/11/2024
Sell
$65.55
7,787
$510K
177,712
NASDAQ ANIP ANI Pharmaceuticals
Lalwani Nikhil / director, officer: PRESIDENT & CEO
03/06/2024
Sell
$65.52
28,965
$1.898M
444,981
NASDAQ ANIP ANI Pharmaceuticals
Lalwani Nikhil / director, officer: PRESIDENT & CEO
03/07/2024
Sell
$66.71
17,060
$1.138M
427,921
NASDAQ ANIP ANI Pharmaceuticals
Lalwani Nikhil / director, officer: PRESIDENT & CEO
03/08/2024
Sell
$67.13
16,292
$1.094M
411,629
NASDAQ ANIP ANI Pharmaceuticals
Marken James G. / officer: SVP OPS & PROD DEV
03/07/2024
Sell
$66.37
24,338
$1.615M
124,492
NASDAQ ANIP ANI Pharmaceuticals
Marken James G. / officer: SVP OPS & PROD DEV
03/07/2024
Sell
$66.71
2,034
$136K
122,458
NASDAQ ANIP ANI Pharmaceuticals
Gutwerg Ori / officer: SVP, GENERICS
03/07/2024
Sell
$66.71
2,494
$166K
80,212
NASDAQ ANIP ANI Pharmaceuticals
Mutz Christopher / officer: HEAD OF RARE DISEASE
03/07/2024
Sell
$66.71
2,110
$141K
85,277
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
03/05/2024
Sell
$65.35
10,093
$660K
872,527
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
03/06/2024
Sell
$65.47
14,822
$970K
857,705
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
03/07/2024
Sell
$66.35
15,085
$1.001M
842,620
NASDAQ ANIP ANI Pharmaceuticals
Mutz Christopher / officer: HEAD OF RARE DISEASE
03/05/2024
Sell
$66.00
5,000
$330K
87,387
NASDAQ ANIP ANI Pharmaceuticals
Pera Antonio R / director
03/04/2024
Sell
$65.20
7,000
$456K
26,627
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
02/29/2024
Sell
$67.67
1,122
$76K
68,652
NASDAQ ANIP ANI Pharmaceuticals
Mutz Christopher / officer: HEAD OF RARE DISEASE
02/29/2024
Sell
$67.67
1,275
$86K
92,387
NASDAQ ANIP ANI Pharmaceuticals
Marken James G. / officer: SVP OPS & PROD DEV
02/29/2024
Sell
$67.67
1,058
$72K
148,830
NASDAQ ANIP ANI Pharmaceuticals
Lalwani Nikhil / director, officer: PRESIDENT & CEO
02/29/2024
Sell
$67.67
10,014
$678K
473,946
NASDAQ ANIP ANI Pharmaceuticals
Gutwerg Ori / officer: SVP, GENERICS
02/29/2024
Sell
$67.67
1,570
$106K
82,706
NASDAQ ANIP ANI Pharmaceuticals
Gassert Chad / officer: SVP - CORP. DEV. & STRATEGY
02/29/2024
Sell
$67.67
1,635
$111K
49,679
NASDAQ ANIP ANI Pharmaceuticals
Davis Krista / officer: SVP, CHIEF HR OFFICER
02/29/2024
Sell
$67.67
1,173
$79K
51,545
NASDAQ ANIP ANI Pharmaceuticals
Cook Meredith / officer: SR. VP, GENERAL COUNSEL & SEC.
02/29/2024
Sell
$67.67
1,173
$79K
60,231
NASDAQ ANIP ANI Pharmaceuticals
CAREY STEPHEN P. / officer: SVP & CFO
02/29/2024
Sell
$67.67
1,914
$130K
189,715
NASDAQ ANIP ANI Pharmaceuticals
Gutwerg Ori / officer: SVP, GENERICS
02/15/2024
Sell
$57.55
1,244
$72K
84,276
NASDAQ ANIP ANI Pharmaceuticals
Mutz Christopher / officer: HEAD OF RARE DISEASE
02/15/2024
Sell
$57.55
1,261
$73K
93,662
NASDAQ ANIP ANI Pharmaceuticals
Cook Meredith / officer: SR. VP, GENERAL COUNSEL & SEC.
02/13/2024
Sell
$56.04
250
$14K
36,799
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
01/19/2024
Sell
$55.57
4,524
$251K
903,312
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
01/22/2024
Sell
$55.95
5,692
$318K
897,620
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
01/23/2024
Sell
$56.44
15,000
$847K
882,620
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
01/16/2024
Sell
$55.63
5,000
$278K
927,620
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
01/17/2024
Sell
$55.11
10,000
$551K
917,620
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
01/18/2024
Sell
$55.30
9,784
$541K
907,836
NASDAQ ANIP ANI Pharmaceuticals
Cook Meredith / officer: SR. VP, GENERAL COUNSEL & SEC.
01/12/2024
Sell
$56.43
250
$14K
37,049
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
12/15/2023
Sell
$52.44
11,974
$628K
970,646
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
12/18/2023
Sell
$52.44
13,026
$683K
957,620
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
12/19/2023
Sell
$52.65
25,000
$1.316M
932,620
NASDAQ ANIP ANI Pharmaceuticals
Cook Meredith / officer: SR. VP, GENERAL COUNSEL & SEC.
12/11/2023
Sell
$49.21
250
$12K
37,299
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
11/17/2023
Sell
$51.00
13,000
$663K
982,620
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
11/14/2023
Sell
$53.17
22,905
$1.218M
1.01M
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
11/15/2023
Sell
$53.64
7,647
$410K
1.00M
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
11/16/2023
Sell
$51.66
6,448
$333K
995,620
NASDAQ ANIP ANI Pharmaceuticals
Davis Krista / officer: SVP, CHIEF HR OFFICER
11/15/2023
Sell
$53.81
2,622
$141K
32,587
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
11/14/2023
Sell
$53.17
22,095
$1.175M
1.01M
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
11/15/2023
Sell
$53.64
7,647
$410K
1.00M
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
11/16/2023
Sell
$51.66
6,448
$333K
996,430
NASDAQ ANIP ANI Pharmaceuticals
Mutz Christopher / officer: HEAD OF RARE DISEASE
11/10/2023
Sell
$52.47
3,000
$157K
63,607
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
10/17/2023
Sell
$58.53
8,758
$513K
1.05M
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
10/18/2023
Sell
$57.78
6,242
$361K
1.04M
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
10/19/2023
Sell
$57.06
10,000
$571K
1.03M
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
10/13/2023
Sell
$57.58
11,937
$687K
1.07M
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
10/16/2023
Sell
$58.31
13,063
$762K
1.06M
NASDAQ ANIP ANI Pharmaceuticals
Gassert Chad / officer: SVP - CORP. DEV. & STRATEGY
10/02/2023
Sell
$56.48
20,000
$1.130M
293,226
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
09/15/2023
Sell
$62.81
16,242
$1.020M
1.12M
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
09/18/2023
Sell
$61.64
8,425
$519K
1.11M
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
09/19/2023
Sell
$61.23
25,333
$1.551M
1.08M
NASDAQ ANIP ANI Pharmaceuticals
Davis Krista / officer: SVP, CHIEF HR OFFICER
09/12/2023
Sell
$61.91
1,486
$92K
35,209
NASDAQ ANIP ANI Pharmaceuticals
Lalwani Nikhil / director, officer: PRESIDENT & CEO
09/08/2023
Sell
$61.94
3,646
$226K
349,744
NASDAQ ANIP ANI Pharmaceuticals
Gassert Chad / officer: SVP - CORP. DEV. & STRATEGY
09/01/2023
Sell
$64.70
20,000
$1.294M
313,226
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
08/28/2023
Sell
$63.06
25,000
$1.577M
1.16M
NASDAQ ANIP ANI Pharmaceuticals
Shanmugam Muthusamy / director, officer: HEAD OF R&D, COO-NOVITIUM OPS
08/29/2023
Sell
$63.37
25,000
$1.584M
1.13M
NASDAQ ANIP ANI Pharmaceuticals
Gutwerg Ori / officer: SVP, GENERICS
08/23/2023
Buy
$31.49
13,502
$425K
76,476
NASDAQ ANIP ANI Pharmaceuticals
Gutwerg Ori / officer: SVP, GENERICS
08/23/2023
Sell
$62.39
13,502
$842K
62,974
NASDAQ ANIP ANI Pharmaceuticals
Gutwerg Ori / officer: SVP, GENERICS
08/23/2023
Sell
$62.39
2,059
$128K
60,915
NASDAQ ANIP ANI Pharmaceuticals
Gutwerg Ori / officer: SVP, GENERICS
08/23/2023
Sell
$31.49
13,502
$425K
13,504
NASDAQ ANIP ANI Pharmaceuticals
Marken James G. / officer: SVP OPS & PROD DEV
08/23/2023
Buy
$33.00
1,667
$55K
137,044
NASDAQ ANIP ANI Pharmaceuticals
Marken James G. / officer: SVP OPS & PROD DEV
08/23/2023
Buy
$40.59
3,750
$152K
135,377
NASDAQ ANIP ANI Pharmaceuticals
Marken James G. / officer: SVP OPS & PROD DEV
08/23/2023
Sell
$63.00
3,932
$248K
133,112
NASDAQ ANIP ANI Pharmaceuticals
Marken James G. / officer: SVP OPS & PROD DEV
08/23/2023
Sell
$40.59
3,750
$152K
0
NASDAQ ANIP ANI Pharmaceuticals
Marken James G. / officer: SVP OPS & PROD DEV
08/23/2023
Sell
$33.00
1,667
$55K
0
NASDAQ ANIP ANI Pharmaceuticals
MERIDIAN VENTURE PARTNERS II LP / 10 percent owner
08/16/2023
Sell
$58.50
200,000
$11.700M
1.82M

COPYRIGHT ©2023 HEALTH STOCKS HUB